Latin America & Caribbean (excluding high income) vs Singapore: Treatment for hypertension, male

Latin America & Caribbean (excluding high income)
46.5%
in 2019
Singapore
58.9%
in 2019
Latin America & Caribbean (excluding high income) rank
11th
Singapore rank
10th

Treatment for hypertension, male over time

  • Latin America & Caribbean (excluding high income)
  • Singapore
2030405060199020042019

How they compare

Singapore currently reports 58.9% against 46.5% in Latin America & Caribbean (excluding high income), a difference of 12.4%.

That makes Singapore's figure about 1.3 times Latin America & Caribbean (excluding high income)'s.

Across all 30 years both countries report, Singapore has been ahead every year.

Latin America & Caribbean (excluding high income) ranks 11th and Singapore ranks 10th of 43 groups.

Singapore has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Latin America & Caribbean (excluding high income) Singapore Difference Ahead
1990s 22.4% 33.8% 11.4% Singapore
2000s 31.8% 44.9% 13.1% Singapore
2010s 42.5% 55.4% 13.0% Singapore

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, male, Latin America & Caribbean (excluding high income) or Singapore?
Singapore, at 58.9% against 46.5% in Latin America & Caribbean (excluding high income) as of 2019.
What is the difference in treatment for hypertension, male between Latin America & Caribbean (excluding high income) and Singapore?
12.4%, with Singapore ahead.
How many years of comparable data are there for Latin America & Caribbean (excluding high income) and Singapore?
30 years are reported by both, from 1990 to 2019.
How do Latin America & Caribbean (excluding high income) and Singapore rank globally for treatment for hypertension, male?
Latin America & Caribbean (excluding high income) ranks 11th and Singapore ranks 10th of 43 groups.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Latin America & Caribbean (excluding high income) vs Singapore: Treatment for hypertension, male. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 19 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/latin-america-and-caribbean-excluding-high-income/singapore/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-male-percent-of-male-adults-ages-30-79-with-hypertension/latin-america-and-caribbean-excluding-high-income/singapore/">Latin America & Caribbean (excluding high income) vs Singapore: Treatment for hypertension, male</a> — Statizoid

About this data

Indicator
Treatment for hypertension, male (% of male adults ages 30-79 with hypertension)
Unit
% of male adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.